Announcing the
2nd Annual Lysosomal Disease Summit
to be held in Melbourne, Australia,
18 – 20 October, 2024

The Lysosomal Disease Summit will bring together metabolic and lysosomal disease healthcare practitioners and researchers from Australia and the surrounding Asia-Pacific region, to address the current challenges facing lysosomal disease clinicians and researchers, discuss the latest research updates, and identify opportunities for improvements in the diagnosis and treatment of lysosomal diseases.

The 2024 Lysosomal Disease Summit is intended to build awareness of the incidence and prevalence of lysosomal disorders, strategize improvements to patient identification and specialist referrals, generate discussion around how to increase metabolic and lysosomal disease workforce resources, and identify steps to overcome barriers to diagnosis and treatment.

In addition, the Summit will provide a forum for researchers and clinicians to share their latest findings and to discuss the challenges and opportunities in the field of lysosomal disease research and management. The Summit will feature targeted educational sessions and panel discussions, as well as a collaboration reception.

The program will be intended for all healthcare practitioners, scientists and researchers, patient advocates, and other interested healthcare professionals.

Questions? Please contact us.


2024 Lysosomal Disease Summit Dates to Remember

1 April, 2024:
Distribution of exhibitor prospectus and support opportunities to all prior supporting companies, and also available by request.

1 May, 2024:
Call for abstracts: Abstract submission website open. Conference scholarship applications will be available in the abstract submission website.

15 June, 2024:
Abstract submission website closes.

1 July, 2024:
Registration for the conference and hotel block opens.

1 July, 2024:
Notification of abstract acceptance for poster or oral presentation at the Lysosomal Disease Summit. Speakers that accept an oral presentation will be eligible for discounted registration rates.

15 July, 2024:
2024 Preliminary Program Released.

16 September, 2024:
Early Registration Ends.


NEW THIS YEAR:
2024 Lysosomal Disease Patient Conference

A Lysosomal Disease Patient Conference will be held on Saturday, 19 October, 2024. The 2024 Patient Conference will be presented by Fabry Australia, in conjunction with the Australian Pompe Association, the Sanfilippo Children’s Foundation and the Gaucher Association of Australia & New Zealand. More information will be available soon on the Fabry Australia website at https://www.fabry.com.au.

NEW THIS YEAR:
Abstract Submission

Clinicians, researchers and other interested individuals will be able to submit scientific abstracts for consideration for oral or poster presentations at the Annual Lysosomal Disease Summit. The online abstract submission system will open on 1 May, 2024, and close on 15 June, 2024. The abstract submission link will be posted here and will be live between 1 May and 15 June, 2024. 

NEW THIS YEAR:
Scholarships

The Lysosomal Disease Summit will be offering 10 scholarships to students and newer researchers interested in attending the annual congress. Applications must be submitted at the time of abstract submission, and all eligible applicants will be considered for the 10 scholarships. More information will be available in the online abstract system beginning 1 May, 2024. 


Lysosomal Disease Summit Topics

The full program for the 2024 Lysosomal Disease Summit will be available August, 2024. Topics for the 1.5 day Lysosomal Disease Summit will include:

  • Completed and current clinical trials
  • Data and opportunities in new therapies
  • Newborn screening
  • Long term outcome data
  • Biomarkers and diagnostics
  • Neurology and lysosomal diseases
  • Patient and family perspectives
  • Inflammation and new therapeutic targets in lysosomal diseases – concepts, preclinical, and early pipeline
  • Special challenges in clinical trials in lysosomal diseases
  • Remote access – added challenges for access to even basic health services in remote areas, much less specialty resources

The 2024 Lysosomal Disease Summit is an important opportunity for clinicians and researchers to come together to advance the field of lysosomal disease research and treatment. The Summit will also provide an opportunity for attendees to network, find collaborators, advance careers, and build relationships.

If you are interested in presenting at the 2024 Lysosomal Disease Summit, please email the Program Manager, Drew Saterdalen at drew@nullsaterdalen.com.


Schedule at a glance

Friday, 18 October:Welcome Reception 18:00 – 20:00
Saturday, 19 October:Education Program 08:00 – 17:00,
Collaboration Reception 18:00 – 19:00
Collaboration Dinner 19:00 – 21:00
Sunday, 20 October: Education Program 08:00 – 12:00

Location & Registration

The 2024 Lysosomal Disease Summit will be held at the Pullman & Mercure Melbourne Albert Park in Melbourne, Australia.


Audience

This summit is intended for researchers, clinicians, and other professionals who are interested in lysosomal diseases. (This event is not intended for patients and families.)


Continuing Professional Development (CPD) Certificate

This Summit will be run independently of an Australian CPD home. However, attendees planning to self-record a CPD activity with the CPD home related to their practice will be required to complete a course evaluation, and then may download/print a certificate upon completion of the Summit. The certificate will confirm involvement in the Summit, and can be used in the case of a future CPD audit.

This Education Activity will be designed to provide a minimum of 10.0 hours of CPD; total number of CPD credits to be determined once agenda is finalized.  


Inquiries

If you have any questions about the 2024 Lysosomal Disease Summit, including available Sponsorship Opportunities, please contact contact the Logistics and Sponsorship Manager, Gudrun at gechterhoff@nulletherio.com.



We respectfully acknowledge the Traditional Owners of the land in which we gather, the Boon Wurrung and Woiwurrung (Wurundjeri) people of the Kulin Nation, and pay our respect to their Elders, past and present.